Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of SGLT2 Inhibitor market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of SGLT2 Inhibitormarket, defines the market attractiveness level of SGLT2 Inhibitor market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of SGLT2 Inhibitor industry, describes the types of SGLT2 Inhibitor market, the applications of major players and the market size, and deeply analyzes the current situation of the global SGLT2 Inhibitor market and the development prospects and opportunities of SGLT2 Inhibitor industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global SGLT2 Inhibitor market in Chapter 13.
By Player:
Merck
AstraZeneca
Pfizer
Johnson & Johnson
Boehringer Ingelheim
Eli Lilly
By Type:
Dapagliflozin
Canagliflozin
Empagliflozin
Other
By End-User:
Hospital Pharmacies
Retail Pharmacies
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 SGLT2 Inhibitor Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 SGLT2 Inhibitor Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 SGLT2 Inhibitor Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 SGLT2 Inhibitor Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise SGLT2 Inhibitor Market Analysis and Outlook to 2022
-
7.1 Global SGLT2 Inhibitor Consumption (2017-2022)
-
7.2 United States SGLT2 Inhibitor Consumption (2017-2022)
-
7.3 Europe SGLT2 Inhibitor Consumption (2017-2022)
-
7.4 China SGLT2 Inhibitor Consumption (2017-2022)
-
7.5 Japan SGLT2 Inhibitor Consumption (2017-2022)
-
7.6 India SGLT2 Inhibitor Consumption (2017-2022)
-
7.7 South Korea SGLT2 Inhibitor Consumption (2017-2022)
8 Region and Country-wise SGLT2 Inhibitor Market Analysis and Outlook to 2028
-
8.1 Global SGLT2 Inhibitor Consumption Forecast (2022-2028)
-
8.2 United States SGLT2 Inhibitor Consumption Forecast (2022-2028)
-
8.3 Europe SGLT2 Inhibitor Consumption Forecast (2022-2028)
-
8.4 China SGLT2 Inhibitor Consumption Forecast (2022-2028)
-
8.5 Japan SGLT2 Inhibitor Consumption Forecast (2022-2028)
-
8.6 India SGLT2 Inhibitor Consumption Forecast (2022-2028)
-
8.7 South Korea SGLT2 Inhibitor Consumption Forecast (2022-2028)
9 Global SGLT2 Inhibitor Market Outlook by Types and Applications to 2022
-
9.1 Global SGLT2 Inhibitor Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Dapagliflozin Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Canagliflozin Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Empagliflozin Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global SGLT2 Inhibitor Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
10 Global SGLT2 Inhibitor Market Outlook by Types and Applications to 2028
-
10.1 Global SGLT2 Inhibitor Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Dapagliflozin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Canagliflozin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Empagliflozin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global SGLT2 Inhibitor Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
11 Global SGLT2 Inhibitor Import and Export Analysis (Top 5 Countries)
-
11.1 Global SGLT2 Inhibitor Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global SGLT2 Inhibitor Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 SGLT2 Inhibitor Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global SGLT2 Inhibitor Market Competitive Analysis
-
14.1 Merck
-
14.1.1 Merck Company Details
-
14.1.2 Merck SGLT2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck SGLT2 Inhibitor Product and Service
-
14.2 AstraZeneca
-
14.2.1 AstraZeneca Company Details
-
14.2.2 AstraZeneca SGLT2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 AstraZeneca SGLT2 Inhibitor Product and Service
-
14.3 Pfizer
-
14.3.1 Pfizer Company Details
-
14.3.2 Pfizer SGLT2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Pfizer SGLT2 Inhibitor Product and Service
-
14.4 Johnson & Johnson
-
14.4.1 Johnson & Johnson Company Details
-
14.4.2 Johnson & Johnson SGLT2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Johnson & Johnson SGLT2 Inhibitor Product and Service
-
14.5 Boehringer Ingelheim
-
14.5.1 Boehringer Ingelheim Company Details
-
14.5.2 Boehringer Ingelheim SGLT2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Boehringer Ingelheim SGLT2 Inhibitor Product and Service
-
14.6 Eli Lilly
-
14.6.1 Eli Lilly Company Details
-
14.6.2 Eli Lilly SGLT2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Eli Lilly SGLT2 Inhibitor Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of SGLT2 Inhibitor
-
Figure SGLT2 Inhibitor Picture
-
Table Global SGLT2 Inhibitor Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global SGLT2 Inhibitor Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global SGLT2 Inhibitor Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global SGLT2 Inhibitor Consumption by Country (2017-2022)
-
Figure United States SGLT2 Inhibitor Consumption and Growth Rate (2017-2022)
-
Table Europe SGLT2 Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure China SGLT2 Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Japan SGLT2 Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure India SGLT2 Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure South Korea SGLT2 Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global SGLT2 Inhibitor Consumption Forecast by Country (2022-2028)
-
Figure United States SGLT2 Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe SGLT2 Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure China SGLT2 Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan SGLT2 Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure India SGLT2 Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea SGLT2 Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dapagliflozin Consumption and Growth Rate (2017-2022)
-
Figure Global Canagliflozin Consumption and Growth Rate (2017-2022)
-
Figure Global Empagliflozin Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Retail Pharmacies Consumption and Growth Rate (2017-2022)
-
Figure Global Dapagliflozin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Canagliflozin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Empagliflozin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Retail Pharmacies Consumption Forecast and Growth Rate (2022-2028)
-
Table Global SGLT2 Inhibitor Import by Region (Top 5 Countries) (2017-2028)
-
Table Global SGLT2 Inhibitor Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck SGLT2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck SGLT2 Inhibitor Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca SGLT2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca SGLT2 Inhibitor Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer SGLT2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer SGLT2 Inhibitor Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson SGLT2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson SGLT2 Inhibitor Product and Service
-
Table Boehringer Ingelheim (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim SGLT2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim SGLT2 Inhibitor Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly SGLT2 Inhibitor Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly SGLT2 Inhibitor Product and Service
-
